StockWatch
·
HomeLiveReports

SAB Biotherapeutics, Inc.

Ticker: 1833214

OverviewP/LShare Hold
values in millions

Revenue & Profit Trend

in millions
RevenueExpenditureNet Profit
-10.30-1.776.7615.29Q1 FY23Q2 FY23Q3 FY23Q3 FY23Q1 FY24Q1 FY24Q2 FY24Q2 FY24

Margin Trend

percentage
OPM %NPM %
-102.00-100.67-99.33-98.00Q1 FY23Q2 FY23Q3 FY23Q3 FY23Q1 FY24Q1 FY24Q2 FY24Q2 FY24
PeriodQ2 FY24Q2 FY24Q1 FY24Q1 FY24Q3 FY23Q3 FY23Q2 FY23Q1 FY23
INCOME
Revenue0.26+0.0%0.26-72.3%0.94+0.0%0.94-26.0%1.27+0.0%1.27+1311.1%0.09-84.5%0.58
Total Income0.26+0.0%0.26-72.3%0.94+0.0%0.94-26.0%1.27+0.0%1.27+1311.1%0.09-84.5%0.58
EXPENSES
Expenditure10.46+0.0%10.46-15.2%12.34+0.0%12.34+87.3%6.59+0.0%6.59+0.5%6.56-17.8%7.98
Tax——————0.000.00
PROFIT
PBT—-7.34—-5.03+1.4%-5.10+0.0%-5.10+25.9%-6.88+6.4%-7.35
Net Profit-7.34+0.0%-7.34-45.9%-5.03+0.0%-5.03+1.4%-5.10+0.0%-5.10+25.9%-6.88+6.4%-7.35
KEY METRICS
OPM %-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%
NPM %-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%
EPS-0.79+0.0%-0.79-46.3%-0.54+0.0%-0.54-440.0%-0.10+89.7%-0.97-592.9%-0.14+6.7%-0.15

Corporate Events

Board MeetingSABS
2026
18Jun

Board Meeting

Annual Meeting of Stockholders to elect Class II directors a…

SEC Filing ↗